14 September 2026 in Journal of IMAB – Annual Proceeding (Scientific Papers)
COVID-19 is associated with a broad spectrum of rhythm and conduction disorders, particularly among hospitalized and critically ill patients. Arrhythmogenesis is multifactorial and reflects systemic inflammation, hypoxaemia, myocardial ischaemia or injury, myocarditis, autonomic imbalance, thromboembolic disease, electrolyte disturbances and drug-related proarrhythmia. Atrial fibrillation is the most frequently reported sustained arrhythmia, while ventricular tachyarrhythmias, bradyarrhythmias and atrioventricular conduction disturbances occur predominantly in patients with severe disease or myocardial injury. Contemporary population-based evidence also indicates that arrhythmic risk may persist beyond the acute infection, although the absolute risk and the contribution of direct viral myocardial injury remain incompletely defined. This review summarizes the principal mechanisms, clinical phenotypes and management considerations of COVID-19-related arrhythmias and highlights emerging evidence concerning post-acute autonomic dysfunction and long-term rhythm complications.
24 August 2026 in Journal of IMAB – Annual Proceeding (Scientific Papers)
The first registered case of COVID-19 in Bulgaria was reported on March 8, 2020. Following the initial manifestation of pulmonary disease and the declaration of an epidemic emergency situation, admissions of patients with cardiovascular diseases (CVD) were significantly reduced. During the period of the COVID-19 pandemic, an increased incidence of acute coronary syndrome (ACS) was observed among patients with newly diagnosed or recently recovered COVID-19 infection. Evidence emerged in the international literature regarding the influence of SARS-CoV-2 on ACE2 receptors and the induction of a systemic inflammatory process in the body. Considering the current concept of atherosclerosis and the role of inflammatory and anti-inflammatory factors, researchers focused their attention on the impact of COVID-19 on atherosclerotic plaque instability and the accelerated progression of ACS. In our follow-up study, the major risk factors for the development of ACS were investigated among patients hospitalized in the Department of Cardiology at University Hospital "Dr Georgi Stranski", Pleven, Bulgaria. Based on the analysis of the obtained results, a risk stratification model for patients with ACS and COVID-19 infection was developed.